Deferred Tax Assets, Valuation Allowance of AXIM BIOTECHNOLOGIES, INC. from 31 Dec 2011 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AXIM BIOTECHNOLOGIES, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2023.
  • AXIM BIOTECHNOLOGIES, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2023 was $10,042,087, a 6.6% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $10,042,087 -$707,001 -6.6% 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q4 2022 $10,749,088 +$4,421,305 +70% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q4 2021 $6,327,783 -$447,747 -6.6% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q4 2020 $6,775,530 +$752,582 +12% 31 Dec 2020 10-K/A 19 Apr 2022 2021 FY
Q4 2019 $6,022,948 +$2,845,602 +90% 31 Dec 2019 10-K/A 20 May 2020 2019 FY
Q4 2018 $3,177,346 +$5,662,975 31 Dec 2018 10-K/A 20 May 2020 2019 FY
Q4 2017 $2,485,629 -$83,296 -3.5% 31 Dec 2017 10-K 08 Apr 2019 2018 FY
Q4 2016 $2,402,333 -$958,533 -66% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $1,443,800 31 Dec 2015 10-K/A 14 Sep 2017 2016 FY
Q4 2013 $16,353 -$2,953,647 -99% 31 Dec 2013 10-K 04 Mar 2014 2013 FY
Q4 2012 $2,970,000 +$4,193,000 31 Dec 2012 10-K 04 Mar 2014 2013 FY
Q4 2011 $1,223,000 31 Dec 2011 10-K 15 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.